Prima Nexus / Events / 2017

International Symposium on Autism 2017: Celebrating BRIMS 10th Year Anniversary

Prima Nexus supported the International Symposium on Autism 2017, which celebrated the 10th anniversary of the Brain Research Institute Monash Sunway (BRIMS), at the Plenary Theatre, Monash University Malaysia, on 14 October 2017.

· Symposium · Supported by Prima Nexus

The Plenary Theatre at Monash University Malaysia, with the symposium title on the screen and the audience seated
The Plenary Theatre during the International Symposium on Autism 2017.

About the symposium

Speakers from Australia, Japan, Taiwan, Korea, Singapore and Malaysia presented clinical and basic research on the diagnosis, causes and treatment of autism. The photographs show a full Plenary Theatre and the registration desk at Monash University Malaysia.

Prima Nexus's part

Prima Nexus supported the symposium. For Prima Nexus’s research support today, see the research platforms page.

More of our work with Monash.

About Prima Nexus

Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. We also run hands-on training for researchers across Malaysia. More about Prima Nexus.

Neuroscience

Work with us

Planning a workshop, a study or a lab set-up? Talk to us.

We run hands-on training at universities and institutes across Malaysia, and support research teams from a single biomarker panel to a multi-site clinical programme.